The Food and Drug Administration (FDA) has approved Lynkuet ® (elinzanetant) for the treatment of moderate to severe vasomotor symptoms (VMS) due to menopause.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback